Dr Jitendra Singh visits ICGEB Trieste, showcases India's biotech research strengths
Synopsis
Key Takeaways
Union Minister of State for Science and Technology Dr Jitendra Singh visited the Trieste component of the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Italy, reviewing advanced research facilities and highlighting India's expanding role in global biotechnology research, scientific training, and technology development. The visit underscored India's deepening institutional ties with one of the world's leading intergovernmental biotech organisations.
Facilities Reviewed at ICGEB Trieste
During the visit, Dr Singh toured the centre's Biotechnology Development Unit, which houses a biopharmaceutical production and training facility and a newly established Biosafety Level-3 laboratory. He also visited the Functional Cell Biology laboratory's high-throughput screening facility. The minister held discussions with ICGEB leadership and interacted with Indian fellows currently working at the centre.
India's BioE3 Policy and ICGEB Alignment
Dr Singh drew attention to the contributions of the ICGEB's India component to the country's biotechnology ecosystem, particularly in areas aligned with the BioE3 policy. The showcase covered biobased chemicals and enzymes, climate-resilient agriculture, carbon capture and utilisation, precision biotherapeutics, and marine and space biomanufacturing.
Among the specific research initiatives highlighted were India's first biofoundry for microbial biomanufacturing, enzyme and yeast systems for ethanol production, biological carbon capture, genome-edited crops, and monoclonal antibodies targeting infectious diseases. This breadth of focus reflects the Centre's alignment with both domestic policy priorities and global sustainability goals.
ICGEB New Delhi: Training and Global Collaboration
India maintains a significant presence within ICGEB's global activities. The Department of Biotechnology (DBT) supports research and development programmes, innovation incubation, and human resource development at the New Delhi component. According to a statement from the Ministry of Science and Technology, as many as 67 researchers from 22 countries undertook or began training at the New Delhi component between 2023 and 2026.
The statement noted that this engagement has been 'complemented by workshops and scientific exchanges in areas including artificial intelligence in biology, drug development, genome editing, carbon capture, microscopy and flow cytometry.' ICGEB New Delhi has also contributed to international scientific training and cooperation with countries across Asia and Africa through joint research, training, and technology transfer.
India's Strategic Role in ICGEB's Developing-Country Mandate
ICGEB's mandate specifically includes providing a platform for scientific collaboration with developing and emerging economies, and India has positioned itself as a key node within this network. The Delhi component's engagement with partner nations through joint research and training programmes reflects India's broader ambitions as a science and technology leader in the Global South.
As India advances its bioeconomy agenda, the visit signals continued high-level commitment to multilateral science diplomacy and reinforces the centrality of institutions like ICGEB in translating research into real-world applications.